Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its structural configuration supports high enantioselectivity, making it valuable in the production of active pharmaceutical ingredients (APIs) for antidepressants and antipsychotics. Commonly employed in asymmetric synthesis due to the stability of its pyrrolidine ring and the reactivity of the bromophenyl group, allowing for efficient cross-coupling reactions. Also utilized in research settings for the design of novel receptor ligands targeting neurological disorders.